{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-002230","form_type":"8-K","ticker":"SLSN","cik":"0000883107","company_name":"SOLESENCE, INC.","filed_at":"2022-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.148106+00:00","generated_at":"2026-06-26T12:54:17.689573+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nanophase posts record FY2021 revenue $29.5M, up 70% YoY; Q4 net loss $0.4M","bullets":["FY2021 revenue $29.5M (70% YoY growth); net income $2.3M ($0.05/sh) vs $1.0M ($0.03) in 2020.","Solésence revenue $18.2M (+170%); API revenue $7.7M (+40%); Advanced Materials $3.6M (-27%).","Q4 2021 revenue $7.4M (+50% YoY); net loss $0.4M vs net income $0.2M in Q4 2020.","Backlog of $33M in shipped/open purchase orders for 2022; Q1 2022 revenue expected above $7M.","Leased 260,000 sq ft facility; added over two dozen team members; TGA GMP clearance for Australia."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-002230","json":"https://secwatch.observer/filing/0001171843-22-002230.json","markdown":"https://secwatch.observer/filing/0001171843-22-002230.md","text":"https://secwatch.observer/filing/0001171843-22-002230.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883107/000117184322002230/0001171843-22-002230-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883107/000117184322002230/f8k_033022.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T12:54:17.689573+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}